Ibsyn Scientific Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 219542.86%
- Profit Growth 540.40%
- Ebitda 684.40%
- Net Worth 610.48%
- Total Assets 537.62%
About Ibsyn Scientific
Ibsyn Scientific Private Limited (ISPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2019 (Five years and 11 months 19 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arnab Majumdar and Kaustav Chakraborty serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900WB2019PTC230845
- Company No.
230845
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Information Technology
Who are the key members and board of directors at Ibsyn Scientific?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaustav Chakraborty  | Director | 11-Mar-2019 | Current |
| Arnab Majumdar | Director | 11-Mar-2019 | Current |
Financial Performance of Ibsyn Scientific.
Ibsyn Scientific Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 219542.86% increase. The company also saw a substantial improvement in profitability, with a 540.4% increase in profit. The company's net worth Soared by an impressive increase of 610.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ibsyn Scientific?
In 2021, Ibsyn Scientific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Paradisica Agrotech Private Limited
Arnab Majumdar and Kaustav Chakraborty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibsyn Scientific?
Unlock and access historical data on people associated with Ibsyn Scientific, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibsyn Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibsyn Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.